1郑州大学第一附属医院儿科,郑州 450052;2郑州大学第一附属医院呼吸科,郑州 450052
网络出版日期: 2025-08-16
基金资助
河南省医学科技攻关计划项目(LHJG20200380)
Research progress of mesenchymal stem cells in the prevention and treatment of broncho-pulmonary dysplasia
1Department of Pediatrics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China; 2Department of Respiratory medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Online published: 2025-08-16
Supported by
Medical Science and Technology
Research Project of Henan Province
支气管肺发育不良(broncho-pulmonary dysplasia,BPD)是早产儿最常见的并发症之一,也是影响早产儿预后的重要因素。然而目前临床对BPD的治疗方法有限且疗效不佳,寻找BPD新的防治方案迫在眉睫。近些年,基础实验及临床研究均发现间充质干细胞移植对BPD有一定疗效,极可能成为治疗BPD新的有效手段。此文从基础和临床研究两个层面总结间充质干细胞对BPD防治作用,并对其远景进行展望。
岳银艳 刘帅 . 间充质干细胞对支气管肺发育不良防治的研究进展[J]. 国际生物制品学杂志, 2022 , 45(2) : 116 -120 . DOI: 10.3760/cma.j.cn311962-20211008-00060
Bronchopulmonary dysplasia (BPD) is one of the most common complications of preterm infants, and it is also an important factor affecting the prognosis of preterm infants. However, the current clinical treatment methods for BPD are limited and the curative effect is poor. It is urgent to find a new prevention and treatment scheme for BPD. In recent years, basic experiments and clinical studies have found that mesenchymal stem cell transplantation has a certain effect on BPD, which is very likely to become a new and effective method for the treatment of BPD. This article summarizes the preventive and therapeutic effects of mesenchymal stem cells on BPD at two levels, basic and clinical research, and look forward to its prospects.
/
| 〈 |
|
〉 |